Noah Nasser, CEO
Noah Nasser joined Omics Data Automation (ODA) in December of 2021 as Chief Executive Officer. He is also an Executive in Residence at the University of Utah, Center for Technology and Commercialization. Nasser has nearly 30 years of experience in biotechnology and genomics. Before ODA, he was CEO at Serimmune, a venture backed biotechnology company focused on the interrogation and analysis of functional immunome. Prior to Seriummune, Nasser served as Chief Commercial Officer at Human Longevity, Inc., a direct-to-consumer health organization combining proprietary imaging and genetic technologies. Nassar has also held the following positions: Chief Commercial Officer, Human Longevity, Inc.; Chief Commercial Officer, Counsyl; VP of Sales and Market Development, Verinata Health, Inc., an Illumina Company; and several leadership roles at Quidel. He earned a B.S. in Molecular Biology from University of California, San Diego.